Amyotrophic lateral sclerosis (ALS) is a fatal paralytic disorder caused by dysfunction and degeneration of motor neurons. Multiple disease-causing mutations, including in the genes for SOD1 and TDP-43, have been identified in ALS. Astrocytes expressing mutant SOD1 are strongly implicated in the pathogenesis of ALS: we have shown that media conditioned by astrocytes carrying mutant SOD1 G93A contains toxic factor(s) that kill motoneurons by activating voltage-sensitive sodium (Na v ) channels. In contrast, a recent study suggests that astrocytes expressing mutated TDP43 contribute to ALS pathology, but do so via cell-autonomous processes and lack non-cell-autonomous toxicity. Here we investigate whether astrocytes that express diverse ALS-causing mutations release toxic factor(s) that induce motoneuron death, and if so, whether they do so via a common pathogenic pathway. We exposed primary cultures of wild-type spinal cord cells to conditioned medium derived from astrocytes (ACM) that express SOD1 (ACM-SOD1 G93A and ACM-SOD1 G86R ) or TDP43 (ACM-TDP43 A315T ) mutants; we show that such exposure rapidly (within 30-60 min) increases dichlorofluorescein (DCF) fluorescence (indicative of nitroxidative stress) and leads to extensive motoneuron-specific death within a few days. Co-application of the diverse ACMs with anti-oxidants Trolox or esculetin (but not with resveratrol) strongly improves motoneuron survival. We also find that co-incubation of the cultures in the ACMs with Na v channel blockers (including mexiletine, spermidine, or riluzole) prevents both intracellular nitroxidative stress and motoneuron death. Together, our data document that two completely unrelated ALS models lead to the death of motoneuron via non-cell-autonomous processes, and show that astrocytes expressing mutations in SOD1 and TDP43 trigger such cell death through a common pathogenic pathway that involves nitroxidative stress, induced at least in part by Na v channel activity.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal paralytic disorder caused by the progressive degeneration of cranial and spinal motoneurons in adulthood, and leading to death by respiratory failure within 3-5 years of diagnosis. Although the majority of ALS cases are sporadic (SALS), ∼10% are familial (FALS) and are generated by mutations in at least 15 identified ALSassociated gene loci (Bento-Abreu et al., 2010; Ferraiuolo et al., 2011) . Dominant mutations in superoxide dismutase 1 (SOD1) and transactive response DNA-binding protein 43 (TARDBP gene, TDP43 protein) are common causes of ALS (Cleveland and Rothstein, 2001; Pasinelli and Brown, 2006; Cozzolino et al., 2012) -to date, more than 150 SOD1 mutations and 40 TARDBP mutations are known to be associated with the ALS phenotype (http://alsod.iop.kcl.ac.uk/; Abel et al., 2012) .
Although the molecular underpinnings of motoneuron degeneration in ALS have not yet been elucidated, in vivo and in vitro studies with use of transgenic mice that carry ALS-causing mutants reveal a large number of pathogenic changes in affected motoneurons: these include mitochondrial dysfunction, hyperexcitability, glutamate excitotoxicity, nitroxidative stress from reactive oxygen species (ROS) or reactive nitrogen species (RNS) (collectively leading to nitroxidative stress), protein aggregation and misfolding, proteasome impairment, cytoskeletal disruption, activation of cell death signals, and dysregulation of transcription and RNA processing (Beckman et al., 2001; Cleveland and Rothstein, 2001; Bruijn et al., 2004; Pasinelli and Brown, 2006; Ferraiuolo et al., 2011; Cozzolino et al., 2012; van Zundert et al., 2012) . Despite these advances in identifying these cellular alterations, however, the origin(s) and interplay between multiple pathogenic processes of motoneuron death in ALS remain largely unknown.
A large number of studies highlight the importance of dysregulated crosstalk between motoneurons and non-neuronal cells in ALS (Ilieva et al., 2009) . The notion that ALS is at least partially a non-cell-autonomous disease originates in a groundbreaking study from Clement et al. (2003) who generated chimeric mice composed of mixtures of normal and SOD1 mutant-expressing cells, and showed that wild-type non-neuronal cells extend the survival of motoneurons carrying mutant SOD1. Additional research has since firmly established the contribution of "deadly neighboring cells" (astrocytes, microglia, oligodendrocytes, and Schwann cells) to the degeneration of motoneurons (Boillée et al., 2006; Yamanaka et al., 2008a,b; Lobsiger et al., 2009; Ilieva et al., 2009 ). Other findings offer compelling evidence that primary mutant SOD1-expressing astrocytes from mouse (Di Giorgio et al., 2007; Nagai et al., 2007; Castillo et al., 2013; Fritz et al., 2013) , rat (Vargas et al., 2006; Cassina et al., 2008) , and humans (Marchetto et al., 2008) effectively and selectively kill motoneurons, but spare interneurons. Importantly, astrocytes differentiated from neuronal progenitor cells (NPCs) obtained either from post-mortem spinal cord tissue or from skin biopsies from FALS (SOD1 mutations and hexanucleotide expansion in C9orf72) and SALS patients also display non-cell-autonomous toxicity, and selectively kill motoneurons in a co-culture model system (Haidet-Phillips et al., 2011; Meyer et al., 2014) . Moreover, astrocytes that express mutants in SOD1 contribute to the pathogenesis of ALS by releasing into the media a toxic factor(s) that kills motoneurons (Nagai et al., 2007; Cassina et al., 2008; Castillo et al., 2013; Fritz et al., 2013) . Little is known regarding the non-cell-autonomous toxicity mediated by mutants other than in SOD1, but a recent study suggests that astrocytes expressing mutated TDP43 (TDP43 M337V ) lack non-cell-autonomous toxicity and contribute to ALS pathology only through cellautonomous processes (Serio et al., 2013) .
Here we show that conditioned medium derived from astrocytes that were harvested from transgenic mice carrying ALScausing mutations in SOD1 (SOD1 G93A and SOD1 G86R ) or TDP43 (TDP43 A315T ) contain toxic factors that trigger motoneuron death. Based on earlier studies which document the involvement of Na v channel-mediated excitability and nitroxidative stress in the pathogenesis of ALS (Ferraiuolo et al., 2011; Cozzolino et al., 2012; van Zundert et al., 2012) , we tested here whether these pathogenic changes are induced in motoneurons via non-cell-autonomous processes. We demonstrate that they do so, and our results indicate that nitroxidative stress within the neurons is mediated by Na v channel activity.
MATERIALS AND METHODS

ANIMALS
Care and use of rodents was in accordance with the US National InstituteofHealthguidelines,andwasapprovedbytheInstitutional Animal Care and Use Committee of Andres Bello University. Hemizygous transgenic mice carrying mutant human SOD1 G93A (high copy number; B6SJL; Cat. No. 002726), wild-type human SOD1 WT (B6SJL; Cat. No. 002297) , mutant mouse SOD1 G86R (FVB crossed on B6SJL background; Cat. No. 005110), or mutant mouse TDP43 A315T (B6.Cg crossed on C57BL/6J; Cat. No. 010700) were originally obtained from Jackson Laboratories (Bar Harbor, USA). Non-transgenic littermates and transgenic mice over-expressing the gene for human SOD1 WT were used as controls. Transgenes were identified by polymerase chain reaction (Wegorzewska et al., 2009; Castillo et al., 2013; Fritz et al., 2013) . The SOD1 G93A mice, but not the hSOD1 WT mice, develop signs of neuromuscular deficits (tremor of the legs and loss of extension reflex of the hind paws) starting at 3 months of age and have an average lifespan of 19-21 weeks (Gurney et al., 1994) . Mice carrying SOD1 G86R (Ripps et al., 1995) or TDP43 A315T (Wegorzewska et al., 2009) develop similar loss of motor function between 3 and 4 months and do not survive to the age of 4 months.
CONDITIONED MEDIA PREPARATION
ACM was prepared as described (Nagai et al., 2007; Castillo et al., 2013; Fritz et al., 2013) . Briefly, cultures of astrocytes were prepared from P1-2 wild-type mice and from transgenic mice expressing human SOD1 G93A , mouse hSOD1 G86R , human SOD1 WT , or mouse TDP43 A315T . Cultures were maintained in DMEM (Hyclone, Cat. No. SH30081.02) containing 10% FBS (Hyclone, Cat. No. SH30071.03; lot ATC31648) and 1% penicillin-streptomycin (Gibco, Cat. No. 15070-063) at 37 • C 5% CO 2 . Cultures reached confluence after 2-3 weeks and contained >95% GFAP + astrocytes. Residual microglia were removed by shaking cultures in an orbital shaker (200 r.p.m. in the incubator) overnight (7 h), at which point media was replaced by spinal culture media (see below). After 7 days, ACM was collected, centrifuged (500 g for 10 min) and stored at −80 • C; before use, it was supplemented with 4.5 mg/ml D-glucose (final concentration) and penicillin/streptomycin, and filtered. A chick hindlimb muscle extract was also added to the ACM before use (Sepulveda et al., 2010) .
For all experiments the ACM was diluted 8-10-fold. The exact dilution was determined for each new batch of ACM by comparing the motoneuron toxicity of the ACM from transgenic animals carrying the ALS-causing mutants (ACM-SOD1 G93A , ACM-SOD1 G86R , and ACM-TDP43 A315T ) to that of ACM generated from mice carrying the wild-type human SOD1 gene (ACM-SOD1 WT ) or from non-transgenic littermates (ACM-NTControl); at the selected dilutions the conditioned media derived from the astrocytes expressing the ALS-causing genes robustly killed motoneurons, whereas the ACM-NT-Control and ACM-SOD1 WT did not affect motoneuron survival. The ACM was applied to ventral spinal cord cultures derived from rats because better quality motoneurons are obtained from rats than from mice; a number of studies have shown that such mixed species co-cultures (from rat, mice, human) do not appear to induce any side effects (e.g., Pehar et al., 2004; Di Giorgio et al., 2007; Nagai et al., 2007; Castillo et al., 2013; Fritz et al., 2013) .
PRIMARY SPINAL CORD NEURONAL CULTURES
Pregnant Sprague-Dawley rats were deeply anesthetized with CO 2 , and primary spinal cultures were prepared from E14 pups (Sepulveda et al., 2010; Castillo et al., 2013; Fritz et al., 2013) . Briefly, whole spinal cords were excised and placed into ice-cold HBSS (Gibco, Cat. No. 14185-052) containing 50 μg/ml penicillin/streptomycin (Gibco, Cat. No. 15070-063) . The dorsal part of the spinal cord was removed using a small razor blade, and the ventral cord was minced and enzymatically treated by incubating in pre-warmed HBSS containing 0.25% trypsin (Gibco, Cat. No. 15090-046) for 20 min at 37 • C. Cells were transferred to a 15 ml tube containing neuronal growth media containing 70% MEM (Gibco, Cat. No. 11090-073) (Gibco, Cat. No. 11360-070) ; they were precipitated, transferred to a new 15-ml-tube containing 2 ml of growth media, re-suspended by mechanical agitation through fire-polished glass Pasteur pipettes of different tip diameters, and counted; 1 × 10 6 cells were plated on freshly prepared poly-Llysine-coated 24-well plates (1 mg/ml; 30.000-70.000 mW; Sigma, Cat. No. P2636). Cells were cultured for 7 days at 37 • C under 5% CO 2 , and supplemented with 45 μg/ml chick hindlimb muscle extract (Sepulveda et al., 2010) ; the media was refreshed every 3 days. 
PHARMACOLOGICAL TREATMENTS IN CULTURE
CELL LABELING AND COUNTING
Motoneurons and interneurons were immunolabeled and counted as previously described (Sepulveda et al., 2010; Castillo et al., 2013; Fritz et al., 2013) . Briefly, primary spinal cultures were fixed at 7 DIV with 4% paraformaldehyde, and immunostained with an antibody against MAP2 (1:400; Santa Cruz Biotechnology) to label all neurons (interneurons plus motoneurons) and with the SMI-32 antibody (1:1,000, Sternberger Monoclonals) to reveal the presence of unphosphorylated neurofilament-H, which is expressed specifically in motoneurons in spinal cord cultures (Urushitani et al., 2006; Nagai et al., 2007) ; antibody binding was visualized with the appropriate fluorescent secondary antibodies. Our wild-type primary spinal cord cultures typically contain at least 6-10% motoneurons until 12 DIV (Sepulveda et al., 2010) . Immunolabeled neurons were documented on an inverted Nikon Eclipse Ti-U microscope equipped with a SPOT Pursuit™ USB CameraCCD (14-bit), Epifl Illuminator, mercury lamp, and Sutter Smart-Shutter with a lambda SC controller. Cells were photographed using a 20× objective; MAP2-and SMI-32-positive neurons were counted offline within 20 randomly chosen fields, and the percentage of SMI-32-positive motoneurons within the total number of MAP2-positive cells was calculated. Each condition was replicated in at least 3 independent cultures, and in duplicate. (Appaix et al., 2012) . After the incubation time, the CM-H 2 DCF-DA-cointaing culture medium was removed and cultures were washed twice with PBS 1× and suspended in culture medium (500 μl final volume). Next, cells were immediately imaged using an inverted Nikon Eclipse Ti-U microscope equipped with a SPOT Pursuit™ USB CameraCCD (14-bit), Epi-fl Illuminator, mercury lamp, and Sutter SmartShutter with a lambda SC controller. Cells were photographed using a 20× objective. As CM-H 2 DCF-DA is a non-fluorescent dye it passively diffuses into cells and is hydrolyzed intracellularly to the DCFH carboxylate anion that is trapped inside; oxidation of DCFH results in the formation of the fluorescent product DCF, with excitation and emission wavelengths λ ex /λ em = 492-495/517-527 nm. The exposure time was kept below 4 s in order to avoid photo-oxidation of the ROS/RNS sensitive dye and for all given treatments fields were exposed for exactly the same amount of time. At least three independent fields were acquired for each condition and at least 10 cells per field were used for quantification of the fluorescence signal. Cells were marked by drawing a region of interest around the cell body, and mean fluorescence intensity was calculated for each cell after subtraction of the background signal using the image analysis module in ImageJ software. Those cells with a relative intensity unit (RIU) of ≥1.5 were counted as positive. Cultures were also incubated with H 2 O 2 (200 μM for 20 min) to serve as a positive control and to normalize the number of DCF-positive cells after ACM application.
NITROXIDATIVE STRESS MEASUREMENTS WITH CM-H
DATA ANALYSIS
ANOVA, followed by post-hoc Tukey tests, was used to detect significant changes. Student's t-tests were used to compare the response of two cell populations to individual treatments. Unless otherwise stated, error bars represent the mean ± s.e.m.; * p < 0.05, * * p < 0.01, * * * p < 0.001 vs. control.
RESULTS
ACM-SOD1 G93A , ACM-SOD1 G86R , OR ACM-TDP43 A315T TRIGGERS DEATH OF CULTURED PRIMARY MOTONEURONS
Here we investigated whether astrocytes expressing diverse ALS causing mutants release toxic factor(s) that induce motoneuron death, and if so, whether a common pathogenic pathway is involved. Astrocyte conditioned media (ACM) was derived from astrocytes that were harvested from mice carrying mutant SOD1 (ACM-SOD1 G93A and ACM-SOD1 G86R ) or TDP43 (ACM-TDP43 A315T ). These media were added at 8-10-fold dilutions (see Materials and Methods) to wild-type primary rat spinal cultures at 4 DIV for 3 days; effects on neuron survival were assessed at 7 DIV ( Figure 1A) . To define the presence of all neurons, an antibody against microtubule-associated protein 2 (MAP2) was used ( Figure 1B ; arrowhead); motoneurons were specifically identified with use of the SMI-32 antibody, which recognizes unphosphorylated neurofilament-H ( Figure 1B ; arrow), as previously described (Urushitani et al., 2006; Nagai et al., 2007; Sepulveda et al., 2010; Castillo et al., 2013; Fritz et al., 2013) . Chronic (3 days) exposure (from 4 to 7 DIV) of spinal cultures to ACM-SOD1 G93A , ACM-SOD1 G86R , or ACM-TDP43 A315T induced ∼50% motoneuron death ( Figures 1C,D) . The number of interneurons was unchanged after application of ACM-SOD1 G93A (91 ± 1% vs. control,
by t-test).
Our findings that ACM-SOD1 G93A and ACM-SOD1 G86R robustly reduces motoneuron cell survival, while sparing interneurons, are consistent with previous studies (Nagai et al., 2007; Castillo et al., 2013; Fritz et al., 2013) . Our results with ACM-TDP43 A315T also show for the first time that astrocytes carrying a TDP43 mutant kill motoneurons through non-cell-autonomous processes. Three types of control media were used throughout this work. (1) "Control" media that was not conditioned by astrocytes. (2) "ACM-NT-Control" media derived from astrocytes that were harvested from littermate mice that were negative for the SOD1 and TDP43 gene. (3) "ACM-SOD1 WT " media derived from astrocytes that were harvested from transgenic mice carrying the nonpathological human wild-type SOD1 gene. None of these media caused motoneuron death ( Figure 1E ). In particular, the finding that ACM-SOD1 WT was not toxic indicates that the factor inducing motoneuron death is specifically due to the SOD1 G93A or SOD1 G86R mutation, rather than to overexpression of the human SOD1 protein. By contrast, we can not exclude the possibility that motoneuron death in our spinal cultures is attributable, at least in part, by increased levels of the TDP43 protein itself. In fact, accumulating data with transgenic models have established that excessive levels of even human wild-type TDP43 result in neurodegeneration, likely as a result in the disruption of RNA metabolism (Wegorzewska et al., 2009; Wils et al., 2010; Igaz et al., 2011; Ling et al., 2013) .
ACM-SOD1 G93A , ACM-SOD1 G86R , OR ACM-TDP43 A315T LEADS TO INCREASES IN INTRACELLULAR ROS/RNS LEVELS
Increased intracellular levels of nitroxidative stress are widely and consistently observed in ALS patients, and in in vitro and in vivo mouse models that express SOD1 mutants (Barber and Shaw, 2010) . To investigate whether soluble toxic factors released by astrocytes that carry SOD1 and TDP43 mutants induce an oxidative burden in primary neurons, we exposed 4 DIV cultures to the diverse ACMs for 30-120 min, washed cells to remove the ACMs, and subsequently loaded the cells with CM-H 2 DCF-DA for 30 min (Figure 2A ). CM-H 2 DCF-DA is a non-fluorescent dye that passively diffuses into cells and is hydrolyzed intracellularly to the DCFH carboxylate anion that is trapped inside; oxidation of DCFH results in the formation of the fluorescent product DCF. Increased intensity in fluorescent DCF could thus reflect detection of certain reactive oxygen and nitrogen species, inducing nitroxidative stress. Combined real-time fluorescence and phase-contrast imaging Graph showing the percentage of motoneurons that survived after treatment with ACMs derived from SOD1 G93A , SOD1 G86R , and TDP43 A315T astrocytes, relative to motoneurons from sister cultures treated with control medium. (E) Graph showing the percentage of motoneurons that survived after treatment with media derived from mouse littermates that were negative for the mutated forms of SOD1 and TDP43 (ACM-NT-Control), or with media derived from transgenic mice carrying the non-pathological human wild-type SOD1 gene (ACM-SOD1 WT ). Survival is shown relative to cultures treated with control media. Values represent mean ± s.e.m. from at least 3 independent experiments performed in duplicate, analyzed by One-Way ANOVA followed by a Tukey post-hoc test. * * * P < 0.001 relative to control medium at 7 DIV.
showed that DCF levels were very low under basal culture conditions, while application of ACM-SOD1 G93A induced both a gradual increase in the intensity and the number of neurons displaying intracellular DCF fluorescence in spinal cord cultures; the fluorescence reached a peak at 30 min ( Figure 2B ). Figure 1 for images of all controls). Together, these results indicate that toxic factors released by astrocytes that carry diverse ALS-causing mutants results in increased nitroxidative stress in spinal cord neurons. The increased nitroxidative stress, however, is unable to induce immediate cell death as the number of motoneurons only starts to significantly reduce after 24 h of ACM application (Supplementary Figure 2) .
ANTI-OXIDANTS PREVENT MOTONEURON DEATH INDUCED BY ACM-SOD1 G93A , ACM-SOD1 G86R , OR ACM-TDP43 A315T
To determine whether the increased nitroxidative stress induced by the diverse ACMs contributes to motoneuron cell death, 4 DIV spinal cord neurons were chronically incubated in a combination of the toxic media plus one of the following antioxidants: Trolox, esculetin or resveratrol ( Figure 3A) . These anti-oxidants are reported to reduce intracellular levels of ROS/RNS (also documented in the present study-see Figure 4 for effects on DCF fluorescence; also see reference citations below). Multiple doses (ranging from 100 nM to 100 μM) of the anti-oxidants were used to assess the survival of motoneurons under control conditions, and after co-application with ACM-SOD1 G93A (see Supplementary Table 1) . For each antioxidant drug, the maximum effect in preventing motoneuron death induced by ACM-SOD1 G93A is displayed in Figure 3B ; the same concentrations of anti-oxidants were also used to test whether they could rescue motoneuron death induced by ACM-SOD1 G86R ( Figure 3C ) or ACM-TDP43 A315T ( Figure 3D ) (see below for details on each anti-oxidant). We also applied these doses of anti-oxidants to cultures incubated with ACM-SOD1 WT and found that none of the anti-oxidants were successful in significantly increasing the number of motoneurons ( Figure 3E) ; similar results were obtained when anti-oxidants were co-applied to spinal cord culture with control media or ACM-NT-Control (not shown), indicating that the beneficial effects of these compounds are specifically attributable to counterbalancing increased nitroxidative stress induced by the diverse toxic ACMs, rather than to simply increasing overall motoneuron cell survival in the cultures.
We first analyzed use of vitamin E, the most potent naturally occurring scavenger of reactive oxygen and nitrogen species known (Tucker and Townsend, 2005) . Extensive studies in ALS patients and mice models have shown, however, that vitamin E application in vivo is not capable of significantly prolonging survival (Gurney et al., 1996; Desnuelle et al., 2001; Ascherio et al., 2005; Graf et al., 2005) These disappointing results are likely related to the findings that vitamin E poorly penetrates the blood-brain barrier, leading to insufficient doses of this anti-oxidant in the central nervous system; IC 50 of vitamin E is between 1.5 and 59 μM while ventricular CSF concentration of this vitamin was found at 0.114 μM (reviewed in Barber and Shaw, 2010) . Here we opted to use Trolox, a watersoluble vitamin E analog that neutralizes ROS (Ghiselli et al., 1995; Khaldy et al., 2000; Barber et al., 2009; Distelmaier et al., 2012) . Chronic co-application of ACM-SOD1 G93A (Figure 3B ) or ACM-TDP43 A315T ( Figure 3D ) with 1 μM of Trolox significantly improved motoneuron survival. In the spinal cord cultures treated with ACM-SOD1 G86R plus Trolox improvement of motoneurons survival was even better and comparable with motoneuron survival obtained under control conditions ( Figure 3C ).
Next we analyzed esculetin and resveratrol, two molecules that have anti-oxidant activities (Lin et al., 2000; Kaneko et al., 2003; Baur and Sinclair, 2006; Barber et al., 2009 ). Esculetin and resveratrol were also identified from a screen of the Spectrum Collection library (consisting of 2000 small compounds) as two of the best-hit molecules, based on their ability to function as effective anti-oxidants by reducing DCF fluorescence and to increase the viability of a mutant SOD1 G93A -expressing cell line; moreover, in silico analysis predicted that these two compounds have specific biochemical properties that allow efficient blood-brain barrier penetration (Barber et al., 2009) . We found that chronic co-application of ACM-SOD1 G93A (Figure 3B ) or ACM-TDP43 A315T ( Figure 3D ) with 25 μM esculetin significantly improved the survival of motoneurons and, in fact, treatment of spinal cord neurons with esculetin plus ACM-SOD1 G86R enhanced motoneuron survival to the level obtained under control conditions ( Figure 3C) .
By contrast, chronic application of resveratrol at 1 μM ( Figure 3B )-as well as at a wide range of concentrations (100 nM to 10 μM) (Supplementary Table 1 of 1 μM resveratrol also did not significantly improve survival of motoneurons incubated with either ACM-SOD1 G86R ( Figure 3C ) or ACM-TDP43 A315T ( Figure 3D ). This negative effect was not related to toxicity of this anti-oxidant, as overall motoneuron cell survival in cultures treated with resveratrol was similar to that achieved under control conditions or cultures treated with ACM-SOD1 WT (see Figure 3E and Supplementary Table 1) .
As discussed before, the application of the diverse ACMs to spinal cord cultures resulted in a strong DCF signals at 30-60 min which then gradually reduced (Figure 2) . However, this is only a transient reduction and cells start to steadily increase DCF fluorescence from 24 h after ACM application; 7 DIV neurons treated chronically for 3 days with the diverse ACMs resulted in robust levels of ROS/RNS (∼70-80% DCF fluorescence relative to H 2 O 2 ) (Supplementary Figure 3) . We next analyzed whether the doses of anti-oxidants that effectively increased cell survival (as shown in Figure 3 ) also prevented the increase in ROS/RNS levels induced by the diverse ACMs ( Figure 4A ). Co-application of ACM-SOD1 G93A plus Trolox (1 μM) or eculetin (25 μM) to spinal cord cultures decreased intracellular DCF fluorescence to a degree similar to that achieved in control cultures ( Figure 4B) . By contrast, resveratrol (1 μM) slightly, but not significantly, reduced nitroxidative stress induced by ACM-SOD1 G93A . We also observed that co-application of Trolox and esculetin with ACM-SOD1 G86R (Figure 4C ) or ACM-TDP43 A315T ( Figure 4D ) had similar beneficial effects in preventing nitroxidative stress; however, again, resveratrol was not effective in significantly reducing the DCF signal. This negative effect of resveratrol was not due to the absence of its anti-oxidant capacity; resveratrol reduced DCF fluorescence induced by H 2 O 2 (200 μM for 20 min) by ∼50% (Supplementary Figure 4) .
Application of these anti-oxidants to control cultures (not shown), or to spinal cord cultures treated with either ACM-NT-Control (not shown) or with ACM-SOD1 WT ( Figure 4E ) revealed that none of these compounds led to significant decreases in basal DCF fluorescence intensity. Together, our data indicate that the favorable effects of Trolox and esculetin on motoneuron survival principally result from counterbalancing the increases in intracellular levels of ROS induced in neurons by the toxic actions of ACM-SOD1 G93A , ACM-SOD1 G86R , or ACM-TDP43 A315T . 
Na V CHANNEL BLOCKERS RESCUE MOTONEURON DEATH INDUCED BY ACM-SOD1 G93A , OR ACM-TDP43 A315T
To gain insights into the mechanism whereby astrocytes expressing diverse ALS-causing mutant proteins increase intracellular ROS/RNS levels and kill motoneurons, we argued that if the conditioned media from the SOD1 and TDP43 mutant astrocytes share a toxic factor(s), then this toxicity must converge to a common target. We recently reported that ACM-SOD1 G93A rapidly (within 30 min) increases neuronal Na v channel mediated excitability; moreover, the application of several blockers of the Na v channel activity (including use of mexiletine, spermidine, and riluzole) reduced the hyperexcitability and prevented motoneuron death induced by ACM-SOD1 G93A (Fritz et al., 2013 ). Hence we tested whether the Na v channel blocker mexiletine (an orally active lidocaine analog that is a local anesthetic and an antiarrhytmic drug that targets the "local anesthetic receptor site" of Na v channels (Ragsdale et al., 1994; Catterall et al., 2005; Olschewski et al., 2009 ), spermidine (a polyamine that affects the gating of varies ion channels and serves as an endogenous, activity-dependent Na v channel blocker (Williams, 1997; Fleidervish et al., 2008) and riluzole which has multiple effects, but at low concentrations (e.g., 100 nM in spinal cord cultures) suppresses neuronal excitability by affecting Na v channels (Kuo et al., 2005; Theiss et al., 2007; Bellingham, 2011; Fritz et al., 2013) can also rescue motoneuron cell death induced by ACM-SOD1 G86R or ACM-TDP43 A315T ( Figure 5A) . We used the same concentrations of these Na v channel blockers as described previously: 25 nM mexiletine, 10 μM spermidine and 100 nM riluzole (Fritz et al., 2013 )-these doses were chosen based on earlier determinations that at these concentrations the Na v channel blockers reduced excitability and also effectively prevented motoneuron cell death induced by ACM-SOD1 G93A , without affecting overall motoneuron cell survival in control cultures (Fritz et al., 2013 ; and see also Figures 5B,E) . To directly compare the beneficial effect of co-application of mexiletine, spermidine or riluzole on the diverse toxic ACMs, we first analyzed motoneuronal survival when these sodium channel blockers were co-applied with ACM-SOD1 G93A ( Figure 5B) . As expected, chronic application (from 4 to 7 DIV) of mexiletine together with ACM-SOD1 G93A to spinal cord cultures prevented motoneuron death in those cultures (Figure 5B) , . Note that co-application of the diverse ACMs with Trolox or esculetin resulted in significant lower DCF fluorescent intensities, whereas resveratrol was not effective. Values represent means ± s.e.m. from at least 3 independent experiments, analyzed by One-Way ANOVA followed by a Tukey post-hoc test. * * P < 0.01, * * * P < 0.001 relative to DCF fluorescence with control media at 7 DIV; ## P < 0.01 and ### P < 0.001 compared to DCF fluorescence with ALS-causing ACM at 7 DIV.
as we have shown earlier (Fritz et al., 2013) . Addition of mexiletine to spinal cord cultures exposed to ACM-SOD1 G86R ( Figure 5C ) and ACM-TDP43 A315T ( Figure 5D ) was also very beneficial and resulted in partially or complete prevention of motoneuron cell death, respectively. Spermidine (10 μM) also completely rescued motoneuron from death induced by ACM-SOD1 G93A (Figure 5B ), ACM-SOD1 G86R (Figure 5C ), or ACM-TDP43 A315T ( Figure 5D ). And furthermore chronic coincubation of spinal cord cultures with 100 nM riluzole and ACM-SOD1 G93A ( Figure 5B) or ACM-SOD1 G86R ( Figure 5C ) completely prevented motoneuron death. The beneficial effects of this drug were less apparent on motoneurons incubated with ACM-TDP43 A315T ( Figure 5D ).
Na V CHANNEL BLOCKERS PREVENT INCREASES IN NITROXIDATIVE STRESS INDUCED BY ACM-SOD1 G93A , ACM-SOD1 G86R , OR ACM-TDP43 A315T
To determine whether the Na v channel-mediated hyperexcitability occurs upstream or downstream of the nitroxidative stress detected by DCF, we co-applied the diverse ACMs with Na v channel blockers to 4 DIV cultures and measured the intensity of DCF fluorescence ( Figure 6A) . The incubation time of the Na v channel blockers with the ACMs was chosen based on the maximum peak in the established time-course of DCF fluorescence for each conditioned media (see Figure 2) : ACM-SOD1 G93A and ACM-TDP43 A315T were tested at 30 min, whereas ACM-SOD1 G86R was tested at 60 min. We found that all three Na v channel blockers significantly reduced DCF fluorescence induced by the diverse ACMs, but to different degrees: mexiletine and spermidine reduced the DCF fluorescent signal induced by ACMs-SOD1 G93A to a level similar to that achieved in untreated cultures, while riluzole decreased DCF fluorescence to below basal levels ( Figure 6B ). Similar effects were observed when these Na v channel blockers were co-applied with ACM-SOD1 G86R (Figure 6C ), ACM-TDP43 A315T (Figure 6D ), or ACM-SOD1 WT ( Figure 6E) . Collectively, these data indicate that astrocytes expressing diverse ALS-causing mutant genes, including in the alleles SOD1 and TDP43, secrete soluble factors that kill wild-type motoneurons Values represent means ± s.e.m. from at least 3 independent experiments, analyzed by One-Way ANOVA followed by a Tukey post-hoc test. * P < 0.05, * * * P < 0.001 relative to survival with control media at 7 DIV; ## P < 0.01 and ### P < 0.001 compared to survival with ALS-causing ACM at 7 DIV.
through a common pathway that involves increased nitroxidative stress, mediated at least in part by Na v channel activity.
DISCUSSION
We provide evidence to demonstrate that astrocytes expressing mutations in SOD1 and TDP43 genes trigger motoneuron pathology and death through non-cell-autonomous processes mediated by the release of soluble toxic factor(s). We show that conditioned media derived from astrocytes that express ALScausing mutations in SOD1 (SOD1 G93A and SOD1 G86R ) and TDP43 (TDP43 A315T ) enhance ROS/RNS levels in neurons, and reduce motoneuron survival. We also document that application of anti-oxidants to spinal cord cultures prevents the increases in intracellular nitroxidative stress induced by diverse ACMs, and counteracts motoneuron death induced by the toxins in these media. Our finding that addition of Na v channel blockers to spinal cord cultures also strongly diminish ACM-induced enhancement of DCF fluorescence and motoneuron death further indicates that Na v channel-mediated excitability occurs upstream of nitroxidative stress and is required for the generation of a certain type of such stress. Collectively, these results indicate that astrocytes that express ALS-causing mutants in SOD1 and TDP43 contribute to ALS pathogenesis by activating a common molecular pathway that involves nitroxidative stress mediated, at least in part, by Na v channel activity.
MUTATIONS IN SOD1 AND TDP43 CAUSE MOTONEURON PATHOLOGY AND DEATH BY NON-CELL-AUTONOMOUS PROCESSES
Ample evidence reveals that astrocytes expressing SOD1 mutants contribute to the pathogenesis of ALS: we and others have also demonstrated that such astrocytes release neurotoxic factors that kill primary motoneurons in culture (Nagai et al., 2007; Cassina et al., 2008; Castillo et al., 2013; Fritz et al., 2013) . In agreement with these studies, we show here that ACM-SOD1 G93A and ACM-SOD1 G86R also extensively and selectively kill primary motoneurons. Additionally, we also examined whether mutants in TDP43 contribute to disease pathogenesis by non-cell-autonomous processes. As for ACM-SOD1 G93A and ACM-SOD1 G86R , we document that exposure of wild-type spinal cord cultures to conditioned media generated by astrocytes derived from transgenic mice that express mutant TDP43 A315T suffices to trigger robust death of motoneurons. These data indicate that astrocytes harboring mutant TDP43 A315T release soluble toxic factor(s) into the media and thereby contribute to disease pathogenesis via non-cell-autonomous processes. Values represent means ± s.e.m. from at least 3 independent experiments, analyzed by One-Way ANOVA followed by a Tukey post-hoc test. * P < 0.05, * * P < 0.01, * * * P < 0.001 relative to DCF fluorescence with control media at 7 DIV; ## P < 0.01 and ### P < 0.001 compared to DCF fluorescence with ALS-causing ACM at 7 DIV.
Our findings are in contrast to a recent publication by Serio et al. (2013) , who showed that astrocytes expressing mutant TDP43 M337V contribute to ALS pathology exclusively via cellautonomous processes, and do not via non-cell-autonomous toxicity. These authors generated astrocytes from induced pluripotent stem cells (IPSCs) derived from a human ALS patient carrying the TDP43 M337V mutation. They report that expression of the TDP43 mutant reduced survival of the human astrocytes, but that co-culturing layers of these TDP43 M337V mutant containing astrocytes with wild-type motoneurons does not lead to motoneuron death. The reason(s) underlying the difference between their results and ours may be related to technical issues associated with the generation of astrocyte populations from human IPSCs, or to the particular TDP43 mutant involved. Additional experiments on the effects that diverse TDP43 mutants expressed in primary rodent astrocytes, as well as in human IPSCs cell lines, have on motoneurons are needed to resolve this discrepancy.
EXPOSURE OF MOTONEURONS TO ACM FROM ASTROCYTES CARRYING MUTATIONS IN SOD1 AND TDP43 ACTIVATES A COMMON PATHOGENIC PATHWAY
Several hypotheses, involving the influence of nitroxidative stress, glutamate excitotoxicity, hyperexcitability, formation of high-molecular-weight aggregates, mitochondrial dysfunction, cytoskeletal disruption, and activation of cell death signals, have been proposed to explain the toxic effect of mutated SOD1 (Beckman et al., 2001; Cleveland and Rothstein, 2001; Bruijn et al., 2004; Pasinelli and Brown, 2006; Cozzolino et al., 2012; van Zundert et al., 2012) . Our results point to critical roles for nitroxidatve stress as well as Na v channel activity in inducing motoneuron death. We and others have previously used cell cultures and slice preparations obtained from transgenic mice expressing mutations in SOD1 to report that Na v channel activity and/or excitability is increased in motoneurons (Kuo et al., 2005; van Zundert et al., 2008; Pambo-Pambo et al., 2009; Pieri et al., 2009; Schuster et al., 2011; Quinlan et al., 2011 and reviewed in ElBasiouny et al., 2010 and van Zundert et al., 2012 . Moreover, using the ACM-SOD1 G93A model system, we recently found that neuronal hyperexcitability, mediated at least in part through elevated Na v channel activity, is essential for inducing motoneuron death. And furthermore, the data presented here indicate that soluble factor(s) secreted by astrocytes carrying other ALScausing mutations in SOD1 (SOD G86R ), and moreover in TDP43 (TDP43 A315T ), kill motoneurons via activation of Na v channels. Soluble mediator(s) secreted by astrocytes with mutations in SOD1 and TDP43 rapidly enhance neuronal nitroxidative stress, andleadtoextensivemotoneurondeathwithinamatterofdays.The rapid elevation in ROS/RNS levels observed in neurons exposed to the toxic ACMs could be due to diffusion of nitroxidative stress generated outside the cell into the motoneurons, or via intracellular de novo generation of ROS/RNS. We favor the second option, as the robust increase in the intensity of DCF fluorescence in motoneurons upon application of toxic ACMs is abolished when Na v channel blockers are applied to the spinal neuron cultures. Note, however, that it has been documented that DCF detects only particular types of reactive species, including hydrogen peroxide (H 2 O 2 ; in combination with cellular peroxidases), hydroxyl radicals ( • OH), and peroxynitrite (ONOO − ) (Estévez et al., 1999; Myhre et al., 2003; Gomes et al., 2005; Martin et al., 2007; Kalyanaraman et al., 2012) , while it is seems insensitive to nitric oxide (NO) and superoxide (O 2
•− ) (Myhre et al., 2003) . It is thus possible that neurons are targets of certain ROS/RNS, including external NO or O 2
•− , that contribute to neuronal nitroxidative stress without being detected by the DCF probe.
With regard to this idea, amply evidence indicates that NO and O 2
•− are produced by ALS glial cells-as a result of either mitochondrial dysfunction, increased NADPH oxidase activity, or inflammation-and play a pivotal role in motoneuron pathology and death (Carter et al., 2009; Drechsel et al., 2012) . For example, Barbeito and collaborators (Vargas et al., 2006; Cassina et al., 2008) report that 40% of motoneurons are lost when they are co-cultured on astrocytes carrying mutated SOD1 G93A and that these astrocytes were found to produce excessive levels of NO and mitochondrial O 2
•− . Moreover, cell death is abrogated when these astrocytes are pre-treated with either anti-oxidants capable of reducing O 2
•− production, or with inhibitors of NO synthase (NOS) (Vargas et al., 2006; Cassina et al., 2008) . Additional studies also indicate that astrocytes and microglia that express mutated SOD1 can generate NO and NADPH oxidase (Nox)-derived ROS (Harraz et al., 2008; Marchetto et al., 2008) . Also, in vivo production of harmful Nox-derived O 2
•− is reported in human SALS patients as well as in the SOD1 G93A transgenic mouse model (Wu et al., 2006; Marden et al., 2007; Harraz et al., 2008) . And finally, recent studies indicate that even extracellular mutant SOD1 and oxidized/misfolded SOD1 protein (both of which are likely to be secreted by cells) can activate microglia and induce nitroxidative stress (Urushitani et al., 2006; Ezzi et al., 2007; Zhao et al., 2010) . Based on these studies, it is plausible that wild-type neurons are targets of external NO or O 2
•− that (1) accumulates in media conditioned by astrocytes carrying ALS mutants, or (2) is generated by surrounding wild-type glial cells (astrocytes and/or microglia) within the spinal cord culture via the action of factors present in the ACM (such as mutated or oxidized/misfolded SOD1 that is secreted by the ALS astrocytes). The presence of these RNS/ROS not necessarily affects externally positioned molecules located in or on the cell membranes of neurons: Thus, NO freely diffuses across cell membranes, and whereas membranes are relatively impermeable to O 2 •− , recent studies indicate that this oxidative specie could permeate across redoxosomal membranes through undefined chloride channels (Mumbengegwi et al., 2008; Carter et al., 2009) . On the basis of our findings presented here and in previous studies, we support the view that induction of Na v channel activation by toxic ACMs is a central factor in initiating motoneuron death in ALS (van Zundert et al., 2012; Fritz et al., 2013) . Na v channel activity can be increased directly by different oxidative species (Hammarström and Gage, 2000; Kassmann et al., 2008; Nani et al., 2010) , but also indirectly by other factors such kinases (e.g., PKC) and the Na v channel β-subunits (Franceschetti et al., 2000; Goldin, 2003; Aman et al., 2009) . It would be interesting to define by mutagenesis whether oxidation of particular amino acids residues (especially methionines and cysteines) influence Na v channel activation; these types of experiments, however, are beyond the scope of this study.
Here we present the following hypothesis to reconcile the studies by others and the data we have present here and previously (Fritz et al., 2013) showing that ACM-SOD1 G93A rapidly (30 min) increases the frequency of calcium transients in cultured spinal cord neurons. Conditioned media derived from astrocytes carrying SOD1 and TDP43 mutants contains NO and/or leads to the generation of NO in spinal cord cultures. This NO in turn induces the activation of Na v channels, leading to excessive calcium influxes through activated Ca v channels; the calcium-mediated activation of mitochondrial respiratory chain complexes and/or Nox complexes will produce intracellular O 2
•− that can interact with NO to spontaneously generate ONOO − that hence can be detected by DCF and promotes intracellular damage, including protein nitration (Beckman et al., 2001; Cleveland and Rothstein, 2001; Martin et al., 2007) . This hypothesis is supported by the fact that limiting the levels of O 2
•− by either reducing Nox activity (Wu et al., 2006; Harraz et al., 2007) or by application of compounds such as Trolox and esculetin (in this study), which have antioxidant and free radical scavenger capacities (Barber et al., 2009) , prevented motoneuron death in diverse ALS models. The finding that the antioxidant resveratrol, unlike Trolox and esculetin, was unable to significantly prevent ACM-induced motoneuron death can be explained by the fact that this compound is a poor free radical scavenger compared to the other two compounds (Barber et al., 2009 ).
DO SOLUBLE TOXIC FACTOR(S) RELEASED BY ALS ASTROCYTES SPECIFICALLY TARGET MOTONEURONS?
Data presented here and previously (Vargas et al., 2006; Di Giorgio et al., 2007; Nagai et al., 2007; Cassina et al., 2008; Marchetto et al., 2008; Castillo et al., 2013; Fritz et al., 2013) show compelling evidence that whereas astrocytes expressing ALS-linked mutations kill motoneurons in spinal cord cultures, they do not affect the survival of spinal cord interneurons. Data shown here and previously (Castillo et al., 2013; Fritz et al., 2013) indicate that independent of neuronal degeneration exposure of spinal cord cultures to toxic ACMs causes pathophysiological changes-including increases in nitroxidative stress, Na v channel activity, neuronal excitability, and intracellular calcium transients-in both motoneurons and interneurons. Moreover, detailed analyses in SOD1-ALS mice also indicate that several pathological changes can be detected in interneurons, and importantly, much before the onset of disease symptoms (Martin et al., 2007; van Zundert et al., 2008 van Zundert et al., , 2012 Ramírez-Jarquín et al., 2013; Wootz et al., 2013) . If both types of neurons are affected in ALS, why then are motoneurons killed and interneurons spared? Using electrophysiological recordings, we recently showed (Fritz et al., 2013 ) that application of ACM-SOD1 G93A significantly increased the persistent sodium inward current (PC Na ) of neurons; this PC Na is mediated by Na v channels (PC Na is greater for Nav 1.1 and Nav 1.6 as compared to Nav 1.2 and Nav 1.3 ), and small increases can have important effects on neuronal excitability, leading to excessive influxes of calcium and sodium (ElBasiouny et al., 2010; van Zundert et al., 2012) . Interestingly, we found that neurons with a large soma (>20 μm diameter) and expressing ≥5 primary dendrites (typical for motoneurons) displayed a larger PC Na compared to neurons with a smaller soma (<20 μm diameter) and expressing ≤4 primary dendrites (typical for interneurons). Moreover, application of ACM-SOD1 G93A further increased the PC Na of neurons, especially of motoneurons. The expression of specific Na v channel subtypes, and subsequent activation of these channels by soluble toxic factor(s) released by ALS astrocytes, will thus induce larger PC Na and in turn cause more sustained calcium influxes in motoneurons compared to interneurons. In addition, because motoneurons have a limited cytosolic calciumbuffering capacity, excessive uptake of calcium by mitochondria would be an initial step in a cascade of events that impair mitochondrial function, thereby likely producing excessive O 2
•− that ultimately leads to motoneuron death (von Lewinski and Keller, 2005; Bento-Abreu et al., 2010; van Zundert et al., 2012) .
In summary, we have elucidated critical roles for both nitroxidative stress and Na v channel activation in the death of motoneuron that is induced in diverse ALS models. Finally, because patients with SALS and FALS display a similar pathology, have comparable clinical symptoms that include hyperexcitability, and experience a beneficial effect of riluzole, it is possible that diverse Na v channel blockers will show benefit in both forms of ALS.
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